ABLYNX SECURES ?1.5 MILLION IN GRANTS
(Thomson Reuters ONE) -
GHENT, Belgium, 5 July 2010 - Ablynx [Euronext Brussels: ABLX], announced today
that it has been awarded a grant worth ?1.1 million by the Flemish agency for
Innovation by Science and Technology (IWT) and a second grant worth ?0.4 million
from the Portuguese government, as part of a consortium.
The IWT grant allows Ablynx to accelerate its pre-clinical development
programme, ALX-0171, for the treatment of respiratory syncytial virus (RSV)
infections. ALX-0171 binds to RSV and neutralises the virus. The Nanobody will
be administered via the lungs and based on in vivo data, it has the potential to
be effective both in the prevention of infection as well as in treatment once
infection has occurred.
ALX-0171 is Ablynx's first Nanobody pre-clinical development candidate to be
delivered through a route other than injection. Like many Nanobodies, ALX-0171
is very stable, making it suitable for inhalation. It can also be manufactured
at relatively low cost in microbial systems.
The grant from the Portuguese government will allow Ablynx and its
collaborators, to explore routes of delivery for Nanobodies into the central
nervous system (CNS) and to develop Nanobodies against therapeutically relevant
CNS targets.
Edwin Moses, CEO and Chairman of Ablynx, said: "We are delighted with IWT's
continued support of Ablynx's Nanobody platform as well as with this second
grant from the Portuguese government which will allow us to further explore and
develop Nanobody-based therapies for CNS diseases where the unmet medical need
is very high. Today, we have over 25 therapeutic programmes in our pipeline
with four Nanobody products in clinical development."
For more information, please contact
Ablynx:
Dr. Edwin Moses
Chairman and CEO
t: +32 (0)9 262 00 07
m: +44 (0)7771 954 193 / +32 (0)473 39 50 68
e: edwin.moses(at)ablynx.com
Eva-Lotta Allan
Chief Business Officer
t: +32 (0)9 262 00 75
m: +32 (0)475 78 36 21 / +44 (0)7990 570 900
e: eva-lotta.allan(at)ablynx.com
[HUG#1429682]
Complete version of the press release: http://hugin.info/137912/R/1429682/376717.pdf
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
All reproduction for further distribution is prohibited.
Source: Ablynx via Thomson Reuters ONE
Unternehmensinformation / Kurzprofil:
Datum: 05.07.2010 - 18:01 Uhr
Sprache: Deutsch
News-ID 23481
Anzahl Zeichen: 0
contact information:
Town:
Ghent
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 240 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ABLYNX SECURES ?1.5 MILLION IN GRANTS"
steht unter der journalistisch-redaktionellen Verantwortung von
Ablynx (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
